We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.47%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.2B
AUM Growth
-$2.64B
(-3.2%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
15.46%
Holding
1,891
New
54
Increased
680
Reduced
1,031
Closed
114
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 2 |
JPMorgan Chase
JPM
|
+$525M |
| 3 |
JD.com
JD
|
+$297M |
| 4 |
Itaú Unibanco
ITUB
|
+$222M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$955M |
| 2 |
Citigroup
C
|
+$523M |
| 3 |
Nektar Therapeutics
NKTR
|
+$334M |
| 4 |
SLB Ltd
SLB
|
+$292M |
| 5 |
Alibaba
BABA
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.67% |
| 2 | Consumer Discretionary | 14.85% |
| 3 | Healthcare | 13.25% |
| 4 | Technology | 13.05% |
| 5 | Energy | 11.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Hamilton Lane
HLNE
$3.91B
| $11.6M | 0.01% |
+311,069
| New | +$11.4M |
|
677
Zoetis
ZTS
$32.5B
| $11.5M | 0.01% |
137,960
-39,872
| -22% | -$3.14M |
|
678
Dollar Tree
DLTR
$24.4B
| $11.3M | 0.01% |
118,797
-73,690
| -38% | -$7.72M |
|
|
GWPH
679
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $11.3M | 0.01% |
100,000
-78,430
| -44% | -$9.86M |
|
680
Alcoa
AA
$11.7B
| $11M | 0.01% |
243,718
+146,811
| +151% | +$7.27M |
|
681
Bio-Rad Laboratories Class A
BIO
$8.86B
| $11M | 0.01% |
43,811
+4,093
| +10% | +$1.04M |
|
682
Equity Lifestyle Properties
ELS
$12.8B
| $10.9M | 0.01% |
248,946
+142
| +0.1% | +$6.04K |
|
683
Nu Skin
NUS
$255M
| $10.9M | 0.01% |
148,041
+138,773
| +1,497% | +$9.85M |
|
684
Kroger
KR
$36.3B
| $10.8M | 0.01% |
452,492
-239,082
| -35% | -$6.49M |
|
685
Broadridge
BR
$18.3B
| $10.7M | 0.01% |
97,729
+83,910
| +607% | +$8.33M |
|
686
Addus HomeCare
ADUS
$2.23B
| $10.6M | 0.01% |
218,284
+1,300
| +0.6% | +$49.9K |
|
|
DESP
687
DELISTED
Despegar.com
DESP
| $10.6M | 0.01% |
339,650
+113,120
| +50% | +$3.37M |
|
688
Everest Group
EG
$15.8B
| $10.2M | 0.01% |
39,662
+583
| +1% | +$140K |
|
689
Cardinal Health
CAH
$54.5B
| $10.2M | 0.01% |
162,073
-151,124
| -48% | -$10.4M |
|
690
Trimble
TRMB
$13.6B
| $10.1M | 0.01% |
282,717
-228,325
| -45% | -$9.2M |
|
|
WBA
691
DELISTED
Walgreens Boots Alliance
WBA
| $10M | 0.01% |
152,982
-730,992
| -83% | -$52.2M |
|
692
Vertex Pharmaceuticals
VRTX
$124B
| $9.99M | 0.01% |
61,315
+58,508
| +2,084% | +$9.56M |
|
693
World Kinect Corp
WKC
$2.06B
| $9.98M | 0.01% |
406,510
+72,526
| +22% | +$1.86M |
|
694
SBA Communications
SBAC
$18.6B
| $9.92M | 0.01% |
58,036
-97,009
| -63% | -$16.1M |
|
695
James River Group Holdings
JRVR
$221M
| $9.89M | 0.01% |
278,952
-172,538
| -38% | -$6.28M |
|
|
GG
696
DELISTED
Goldcorp Inc
GG
| $9.81M | 0.01% |
709,600
+159,600
| +29% | +$2.16M |
|
697
American Water Works
AWK
$27B
| $9.79M | 0.01% |
119,152
-46,741
| -28% | -$3.82M |
|
698
Wheaton Precious Metals
WPM
$49.8B
| $9.66M | 0.01% |
+474,460
| New | +$9.74M |
|
|
NXTM
699
DELISTED
NxStage Medical Inc.
NXTM
| $9.64M | 0.01% |
387,602
-38,282
| -9% | -$931K |
|
700
RPC Inc
RES
$1.14B
| $9.61M | 0.01% |
532,760
-551,510
| -51% | -$11.6M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2018 Portfolio in Review
As of Q1 2018, OppenheimerFunds held 1,891 positions worth $80.2B, down 3.2% from $82.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
OppenheimerFunds's Q1 2018 filing shows 54 new, 680 increased, 1,031 reduced and 114 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M. The largest sale was Alphabet (Google) Class C, an estimated $955M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- OppenheimerFunds's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M.
- OppenheimerFunds added most to Alphabet (Google) Class A in Q1 2018, an estimated $639M increase.
- OppenheimerFunds's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $955M.
- OppenheimerFunds fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $77.3M.
- OppenheimerFunds's ten largest holdings make up 15% of its $80.2B portfolio in Q1 2018.
- OppenheimerFunds opened 54 new positions and closed 114 in Q1 2018.
- OppenheimerFunds's portfolio value fell 3.2% quarter-over-quarter to $80.2B.
Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.